GALNT14 and hepatocellular carcinoma: Recently, a single nucleotide polymorphism (SNP) on GALNT14 has been repetitively shown to correlate with the therapeutic responses of combination chemotherapy in independent cohorts of patients with far-advanced HCC, and the TT genotype of the SNP, rs9679162, was correlated with a good post-chemotherapy prognosis (2,4).